Dr. Reid Robison

The mental health care company Numinus Wellness Inc. (OTCQX: NUMIF) will provide its evidence-based, ketamine-assisted psychotherapy (KAP) to HempLucid’s eligible staff through a pilot program to help in the improvement of employee mental health.  The Pilot Ketamine...

Novamind Inc. (OTCQB: NVMDF) has announced that it will offer a model of psychedelic-assisted group therapy. Under the name Groups by Novamind, the therapy model will offer psychedelic integration and in-person group psychedelic-assisted psychotherapy for four to ten individuals delivered as drop-...

Novamind Inc. (OTCQB: NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major depressive disorder sponsored by the Usona Institute. The company completed first patient randomization at its Draper, Utah research site. "The Psilocybin Trial is a...

Novamind Strikes Research Deal With Merck Psychedelics company Novamind (PINK: NVMDF) announced a subsidiary has been selected as a research site for a clinical trial of a compound developed by pharma giant Merck (NYSE: MRK). The phase II trial will assess the efficacy and safety of MK-1942,...

District of Columbia To Include Psychedelics Decriminalization Measure on November Ballot The District of Columbia will likely become the nation’s second jurisdiction to include a psychedelics decriminalization measure in November. Oregon made a similar announcement last week, and will...